2014 to 2021 Saw Increase in Use of Active Surveillance for Low-Risk Prostate Cancer
WEDNESDAY, March 8, 2023 (HealthDay News) -- From 2014 to 2021, the rates of active surveillance for low-risk prostate cancer increased, but considerable practice- and practitioner-level variation is seen in its use, according to a study published online March 2 in JAMA Network Open.
Matthew R. Cooperberg, M.D., M.P.H., from the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, and colleagues characterized trends over time and practice- and practitioner-level variation in the use of active surveillance for men with low-risk prostate cancer newly diagnosed between Jan. 1, 2014, and June 1, 2021. Data were included for 20,809 men in the American Urological Association Quality Registry with known primary treatment.
The researchers found that from 2014 to 2021, the rates of active surveillance increased sharply and consistently from 26.5 to 59.6 percent. There was variation noted in the use of active surveillance, from 4.0 to 78.0 percent at the urology practice level and from 0 to 100 percent at the level of the practitioner. Year of diagnosis was the variable most strongly associated with active surveillance on multivariable analysis; age, race, and prostate-specific antigen value at diagnosis all were associated with odds of active surveillance.
"Rates of active surveillance nationally continue to increase rapidly, but overtreatment of low-risk disease remains excessive," the authors write. "Moreover, individual practices vary radically in their use of active surveillance, as do individual practitioners even within a given practice."
Two authors disclosed financial ties to the pharmaceutical industry.
Related Posts
Diabetes Drug Might Help Women With Preeclampsia Prolong Their Pregnancy
THURSDAY, Sept. 23, 2021 (HealthDay News) -- Metformin, a commonly prescribed...
Quitting Smoking Tied to Better Survival in Head, Neck Squamous Cell Carcinoma
TUESDAY, Feb. 14, 2023 (HealthDay News) -- Smoking cessation for >10 years is...
Las máscaras N-95 son indispensables para la ómicron, pero hay muchas falsificaciones
JUEVES, 30 de diciembre de 2021 (HealthDay News) -- Mientras ve cómo la variante...
After Years of Decline, Abortions Climb in U.S.
WEDNESDAY, June 15, 2022 (HealthDay News) -- There was a significant rise in...